Blog

Here are some of the studies presented at the European Society for Medical Oncology’s recent virtual congress that grabbed our attention. Nivolumab plus cabozantinib could be a new first-line treatment option People with advanced or metastatic kidney cancer who were treated with the novel combination of the PD-1 checkpoint inhibitor nivolumab (Opdivo) plus the cabozantinib (Cabometyx) lived longer and without…

As the KCA’s communications intern, I’ve gotten the chance to learn, grow, and connect to others. I’ve been able to discover how nonprofits work and learn from coworkers who are extremely passionate about what they do. My six-month internship is winding down and it’s a great opportunity to look back at the last half year.  I have gotten the chance…

Craig DePriester serves as the Vice Chair of the KCA's Board of Directors and currently works as the General Manager and Vice President of Operations at HealthCare Partners, A DaVita Medical Group. We spoke with Craig about what motivated him to join our Board of Directors and enter the medical field.  What motivated you to get involved with the Kidney…

 After suffering from severe flank pain all summer, Matty McClain decided to visit his general practitioner in late 2018. Blood tests results seemed normal, but when Matty examined his results more closely online, he noticed that his creatinine had gone from less than .99 milligrams/deciliters (mg/dL)* to 1.36mgl/dL and his estimated glomerular filtration rate from over 90 millimeters/minute (mL/min)* to…

HOUSTON – September 17, 2020 – The Kidney Cancer Association (KCA) presented two Advanced Discovery Awards and four Young Investigator Awards – a total of $1.3 million in funding – to researchers from around the world who are working to advance early detection of and discover new treatments for kidney cancer. “We’re incredibly excited to support this year’s awardees. For…

Nancy Moldawer, RN, MSN, is the Co-Chair of the KCA’s Clinical Advisory Board and currently works at Cedars Sinai Medical Center. We spoke to Nancy about her work in the KCA and in medicine.  How long have you been working with the KCA and what motivated you to get involved? I have been a part of the Nurse Advisory Board…

 Early in July, stacks of orange-colored books began popping up on Instagram. Michele Voss, a book lover whose Instagram account is devoted to what she’s been reading, wanted to do something special to honor her husband, Ted Voss, who had kidney cancer and died in 2018.  “I had been thinking about it for a while. People post [pictures of] book…

In honor of our 30th anniversary, we’re catching up with former grant recipients to hear how their work has impacted kidney cancer care and research. Dr. Xiao Wei received the 2018 Andrew C. Novick & P.H.M de Mulder Research Scholar Award. She is a physician at the Dana-Farber Cancer Institute and an Instructor in medicine at Harvard Medical School in Boston,…

In honor of our 30th anniversary, we’re catching up with former grant recipients to hear how their work has impacted kidney cancer care and research. Dr. Thai Ho is a medical oncologist, internist, and an Associate Professor in the Division of Hematology/Oncology at the Mayo Clinic in Phoenix, Arizona. Dr. Ho received the 2011 ASCO Conquer Cancer Foundation Young Investigator Award while…

In honor of our 30th anniversary, we’re catching up with former grant recipients to hear how their work has impacted kidney cancer care and research. Dr. Raj Gopal is a clinician and researcher at Massachusetts General Hospital in Boston, Massachusetts. He received a 2016 ASCO Conquer Cancer Young Investigator Award, supported by the Kidney Cancer Association. We spoke to Dr. Gopal about…